CB
OTLK icon

CNB Bank’s Outlook Therapeutics OTLK Stock Holding History

CNB Bank’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$10.9K – 473
2023
Q1 		$10.9K Hold
500
– – 0.01% 340
2022
Q4 		$10.8K Hold
500
– – 0.01% 321
2022
Q3 		$12K Hold
500
– – 0.01% 318
2022
Q2 		$10K Hold
500
– – 0.01% 319
2022
Q1 		$18K Hold
500
– – 0.01% 293
2021
Q4 		$14K Hold
500
– – 0.01% 313
2021
Q3 		$22K Hold
500
– – 0.01% 284
2021
Q2 		$25K Hold
500
– – 0.02% 279
2021
Q1 		$23K Hold
500
– – 0.02% 275
2020
Q4 		$13K Buy
+500
New +$10.4K 0.01% 306

Other funds holding OTLK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

CNB Bank's OTLK Position: Q2 2023 in Review

CNB Bank sold out of Outlook Therapeutics (OTLK) in Q2 2023, closing a stake of 500 shares — an estimated $10.9K sold.

CNB Bank first reported a position in OTLK in Q4 2020 and held it in 10 quarters. The position peaked at $25K in Q2 2021. 87 funds tracked by Wall St. Rank hold OTLK as of Q2 2023.

  • CNB Bank reported no remaining Outlook Therapeutics position as of Q2 2023 after selling out during the quarter.
  • CNB Bank sold 500 Outlook Therapeutics shares in Q2 2023, an estimated $10.9K.
  • CNB Bank first reported a position in Outlook Therapeutics in Q4 2020 and held it in 10 quarters.
  • CNB Bank's Outlook Therapeutics position peaked at $25K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2023.

Based on CNB Bank's 13F filing for Q2 2023, filed 8 Aug 2023.